POSA125 Comparing Healthcare Cost Among Empagliflozin, DPP-4 Inhibitors and GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus: A German Claims Data Analysis
Abstract
Authors
T Wilke A Stuermlinger N Picker S Müller B Deiters A Dittmar J Aberle M Gabler